Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status

Area of Science:

• Infectious Diseases
• Vaccinology
• Public Health

Background:

• The COVID-19 pandemic continues, with the SARS-CoV-2 Delta variant presenting unique challenges.
• Understanding the impact of vaccination on Delta variant infections is crucial.

Purpose of the Study:

• To evaluate the effectiveness of COVID-19 vaccination against severe outcomes in patients infected with the SARS-CoV-2 Delta variant.
• To compare clinical characteristics and outcomes between vaccinated and unvaccinated patients.

Main Methods:

• Multilevel logistic regression analysis of 197 hospitalized patients with the Delta variant (44 vaccinated, 153 unvaccinated).
• Comparison of patient demographics, CT lung involvement, Padua score, oxygen saturation, ventilation needs, arterial blood gas (ABG) dynamics, ICU admission, and mortality rates.

Main Results:

• Unvaccinated patients showed a significantly higher propensity for severe infection (p < 0.05).
• Elevated rates of lung involvement, oxygen requirement, ICU admission, and mortality were observed in the unvaccinated group.

Conclusions:

• COVID-19 vaccines demonstrate substantial efficacy in preventing severe disease.
• Vaccination significantly lowers ICU admission rates and mortality among hospitalized patients with the Delta variant.